RESULTS
The FP of solutions to which neither urine nor collagen was added was about 53 (mg/Ioo ml)2. The effect on the FP of 28 urine samples from healthy adults was investigated.
When 0.25 ml urine was added to I I .25 ml of the solution, giving a urine concentration of 2.2 %, the mean FP was raised to a figure of about 105 (mg/~oo ml)2 (Table  I ). This rise in FP showed that the urine contained a substance which inhibited the formation of hydroxyapatite.
Preliminarv boiling of the urine had no effect on its inhibitory power. The rise in FP cannot be due to a shift in the calcium from the ionized to the bound form caused by the addition of urine, since the concentration of ionized calcium as determined with murexide does not change significantly.
A change in ionic strength is no factor either, because it is not altered significantly by such a small quantity of urine. Finally, the urinary citrate is not responsible for raising the FP, for, if 22 mg citrate/ liter is added to the solutions (a concentration corresponding to 1,000 mg citrate/liter urine, which is above the finding in any one the urine samples in our experiments), the resultant FP is the same as the control. Using our method for measuring the FP, we were able to note the following:
The urine passing through an anion exchanger ( (Fig. 3) . Account was taken of the pyrophosphate content (0.1 % expressed as P) of the orthophosphate in the solution, the solution with no addition of pyrophosphate actually containing I o ,ug/liter pyrophosphate-P.
Even with as low a concentration as 30 pg P/liter, i.e., IO@ M, the inhibitory effect was significant.
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Now, the addition of 0.25 ml urine to the solution gave a mean pyrophosphate concentration of 49 /*g P/liter.
In F' lg. 3 this concentration corresponds to a FP of 77 (mg/~oo ml)2, the pyrophosphate content of the orthophosphate being taken into account. However, if the FP was determined experimentally for each of the 28 urine samples, the mean FP was found to be 105 (mg/~oo m1)2. The difference between 77 and 105 (mg/ IOO m1)2 must be due to one or several other inhibitory substances. Furthermore, the FP of the 28 samples was plotted against the pyrophosphate content in the solution in Fig. 3 , those plots appearing in a disorderly fashion above the line and showing that the FP of the urine samples was usually above the figure calculated for a corresponding pyrophosphate concentration. Consequently, other factors besides pyrophosphate must be present in urine and must inhibit the formation of h)-droxyapatite.
The nature of a second inhibitor is under investigation. 
